ALS Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ALS's estimated annual revenue is currently $15.5M per year.(i)
  • ALS's estimated revenue per employee is $155,000

Employee Data

  • ALS has 100 Employees.(i)
  • ALS grew their employee count by 27% last year.

ALS's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
Senior Project Manager Reveal Email/Phone
3
Supply Chain LeaderReveal Email/Phone
4
EngineerReveal Email/Phone
5
Computational BiologistReveal Email/Phone
6
Engineer IIReveal Email/Phone
7
Senior Principal Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M72-13%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
$0.9M11-39%N/AN/A
#6
$1.7M1110%N/AN/A
#7
$0.6M4-33%N/AN/A
#8
$4.8M31-6%N/AN/A
#9
$6.4M413%N/AN/A
#10
$4.2M27-18%N/AN/A
Add Company

What Is ALS?

Applied LifeSciences & Systems, or ALS-S, is a bio-systems company focused on improving animal health and productivity in the poultry, livestock and aquaculture industries. To learn more about solutions from ALS-S, visit: www.als-s.com.

keywords:N/A

N/A

Total Funding

100

Number of Employees

$15.5M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ALS News

2022-04-20 - Support Saturday's Walk to Defeat ALS in Raleigh

ABC11 Together is a proud sponsor of the Walk to Defeat ALS.

2022-04-20 - First AI-Powered ALS Educational Platform Launches for the Public

Grassroots ALS nonprofit Paint for a Cure and Conversational Video inventor StoryFile have partnered to provide life-improving resources for...

2022-03-30 - FDA advisers to review ALS drug funded by Ice Bucket Challenge

An FDA advisory committee will review Amylyx's ALS drug.The research was funded in part by the Ice Bucket Challenge, but experts question...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22M10049%N/A
#2
$35M1008%N/A
#3
$15M100-3%N/A
#4
$3.5M10010%N/A
#5
$25.4M1016%N/A